Valisure: “Valisure Citizen Petition on Ranitidine.” Sandoz Inc.: “Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product.” Bloomberg: “Carcinogen in Zantac Leads to Another Shipment Halt, Recall.” Health Canada: “Health Canada requests that companies stop distributing ranitidine drugs in… Read More »
Women who experienced six or more symptoms of post-traumatic stress disorder (PTSD) at some point in life had a twofold greater risk of developing ovarian cancer compared with women who never had any PTSD symptoms, according to a new study from researchers at Harvard T.H. Chan School of Public Health and Moffitt Cancer Center. The… Read More »
Roche has been hoping its Tecentriq could put up the kind of life-lengthening numbers in squamous non-small cell lung cancer (NSCLC) that could help it compete with Merck’s Keytruda—but no dice. The Swiss drugmaker Tuesday unveiled results showing that its Tecentriq-chemo combo failed to outdo solo chemo at extending the lives of previously untreated patients.… Read More »
Fatigue Prostock-studio/Shutterstock While you may write-off your exhaustion to a busy schedule or stressful workload, constant fatigue that isn’t getting better warrants a visit to your doctor to rule out something more serious. “When you’re not able to produce healthy red blood cells [as those with blood cancers can’t] you can develop anemia,” explains Dr.… Read More »
Cancer drugs currently account for 27% of all new drug approvals in the U.S. since 2010, a dramatic increase from the 4% share of the 1980s, a newly completed analysis from the Tufts Center for the Study of Drug Development shows. From 1980 through 2018, the Food and Drug Administration approved a total of 126… Read More »